Sprint Bag
/
Mission
/
Explore
Write
/
Organizations
/
Agomab Therapeutics NV
You
AT
Agomab Therapeutics NV
Company · Health
Statements
1
Sightings
1
Years covered
2026 – now
Primary source
SEC Form 20-F
All statements
2026 – now
Current
Our mission is to develop disease-modifying therapeutics that aim to resolve fibrosis and restore organ function to enable patients with these disorders to live fuller and healthier lives.
Mission · Product offering · SEC Form 20-F, filed 2026-04-23
Organization
Type
Company
Industry
Health
Location
US
Size
—
Website
—
Status
active
All filings on SEC EDGAR ↗